Indeed, Xist loss resulted in X reactivation and the induction of genome-wide changes associated with cancer, including dysregulation of oncogenes or tumor suppressor genes involved in MPN and MDS [32]. The gene discussed is XIST; the disease is myeloproliferative neoplasm.